Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

for
Cataract
Location: San Francisco CA, Overland Park KS, Minneapolis MN,
Sponsor: Chakshu Research, Inc.

Sex: All

Age: 50 - 70+

Code: NCT00793091

Phase 2, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: San Francisco CA, Reno NV, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: San Francisco CA, Palo Alto CA, Santa Rosa CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase 2, Phase 3, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: San Francisco CA, Reno NV, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

for
Thyroid Eye Disease, TED, Graves Orbitopathy
Location: San Francisco CA, Las Vegas NV, Reno NV, Canoga Park CA,
Sponsor: Sling Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07753603

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase 3, Recruiting
New

A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)

for
HIV
Location: San Francisco CA, Toronto, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07850609

Phase 2, Recruiting

Personalized HIV and STI Testing Tool

for
Risk Reduction, HIV,
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.

Sex: Male

Age: 18 - 29

Code: NCT03109899

Recruiting

A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW

for
HIV Prevention, Pre-exposure Prophylaxis (PrEP), Risk Reduction,
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.

Sex: Male

Age: 18+

Code: NCT05474313

Recruiting

PrEPsmart 2-1-1 Pilot

for
HIV-1-infection
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.

Sex: Male

Age: 18+

Code: NCT06631365

Phase 2, Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

for
HIV Infections
Location: San Francisco CA, Nashville TN, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 60

Code: NCT06665646

Phase 1, Recruiting

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

for
HIV
Location: San Francisco CA, Houston TX, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07390955

Phase 1, Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: San Francisco CA, Los Angeles CA, Scottsdale AZ,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: San Francisco CA, Irvine CA, Eugene OR, Happy Valley OR,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: San Francisco CA, Berkeley CA, San Mateo CA, Vallejo CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: San Francisco CA, South San Francisco CA, Oakland CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting

TruGraf® Long-term Clinical Outcomes Study

for
Kidney Transplant Rejection
Location: San Francisco CA, Sacramento CA, Fresno CA,
Sponsor: Transplant Genomics, Inc.

Sex: All

Age: 18+

Code: NCT04491552

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: San Francisco CA, South San Francisco CA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase 3, Recruiting